Skip to main content
ACS Omega logoLink to ACS Omega
. 2026 Jan 6;11(2):3666. doi: 10.1021/acsomega.5c13441

Retraction of “Rosuvastatin Attenuates Rheumatoid Arthritis-Associated Manifestations via Modulation of the Pro- and Anti-inflammatory Cytokine Network: A Combination of In Vitro and In Vivo Studies”

Sumera Qasim, Alamgeer , Saima Kalsoom, Muhammad Shahzad, Ishfaq Ali Bukhari, Fahim Vohra, Sibtain Afzal
PMCID: PMC12824925  PMID: 41585680

The Editor retracts “Rosuvastatin Attenuates Rheumatoid Arthritis-Associated Manifestations via Modulation of the Pro- and Anti-inflammatory Cytokine Network: A Combination of In Vitro and In Vivo Studies” (DOI: 10.1021/acsomega.0c05054) due raw data that could not be verified, the radiographic image in Figure 3c (identified as piroxicam-treated) was found to be a duplication to Figure 4b (identified as normal control) in 10.1021/acsomega.0c05698, and the radiographic image in Figure 3a (normal control) was found to be duplicated from Figure 4c (amlodipine-treated group) in 10.1007/s10787-020-00692-9. In addition, the controls were reused across these three experiments, which raises concerns about proper experimental set up and therefore the reliability of the results presented. As such, the article is being retracted.

The original article was published on January 14, 2021, and retracted on January 6, 2026.


Articles from ACS Omega are provided here courtesy of American Chemical Society

RESOURCES